Hepion Pharmaceuticals, Inc.
HEPA· OTC
HEPAHepion Pharmaceuticals, Inc.
Filed Apr 8, 2025 · 10-K · 98 days after period end · 0001641172-25-003250
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 |
| Net Income | -$1.55M | -$11.06M | -$6.81M | -$9.72M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Hepion Pharmaceuticals, Inc. · CIK 1583771 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Apr 8, 2025 · 98 d after period end
